As steroid hormones are central regulators of systemic metabolism, ERs and ARs increase glucose tolerance and restrain visceral fat accumulation, and, thus, in postmenopausal women with reduced ERα signalling and with individuals with aromatase deficiency having compromised AR to ER conversion, tend to have increased adiposity, which is a risk factor for cancer development [8]. The gene discussed is ESR1; the disease is cancer.